SGMT vs. PRCT
SGMT (Sagimet Biosciences Inc.) and PRCT (PROCEPT BioRobotics Corporation) are both stocks. Both are in the Healthcare sector — SGMT in Biotechnology, PRCT in Medical Devices. Over the past year, SGMT returned 88.98% vs -56.11% for PRCT. At a 0.21 correlation, their price movements are largely independent.
Performance
SGMT vs. PRCT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SGMT achieves a 15.88% return, which is significantly higher than PRCT's -16.31% return.
SGMT
- 1D
- 1.03%
- 1M
- -13.16%
- YTD
- 15.88%
- 6M
- 6.19%
- 1Y
- 88.98%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PRCT
- 1D
- -1.61%
- 1M
- 6.04%
- YTD
- -16.31%
- 6M
- -20.64%
- 1Y
- -56.11%
- 3Y*
- -6.78%
- 5Y*
- —
- 10Y*
- —
SGMT vs. PRCT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
SGMT Sagimet Biosciences Inc. | 15.88% | 31.56% | -16.97% | -66.02% |
PRCT PROCEPT BioRobotics Corporation | -16.31% | -60.93% | 92.13% | 14.82% |
Correlation
The correlation between SGMT and PRCT is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jul 17, 2023 | 0.21 |
Fundamentals
SGMT:
-$1.34
PRCT:
-$2.46
SGMT:
$0.00
PRCT:
$322.02M
SGMT:
$0.00
PRCT:
$206.01M
SGMT:
-$48.74M
PRCT:
-$90.33M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SGMT vs. PRCT — Risk / Return Rank
SGMT
PRCT
SGMT vs. PRCT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sagimet Biosciences Inc. (SGMT) and PROCEPT BioRobotics Corporation (PRCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SGMT | PRCT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.80 | ||
| Sortino ratioReturn per unit of downside risk | +3.65 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 0.83 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 1.61 | -0.84 | +2.45 |
| Martin ratioReturn relative to average drawdown | 2.67 | -1.17 | +3.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SGMT | PRCT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.86 | -0.94 | +1.80 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.17 | -0.15 | -0.02 |
Drawdowns
SGMT vs. PRCT - Drawdown Comparison
The maximum SGMT drawdown since its inception was -89.69%, which is greater than PRCT's maximum drawdown of -78.17%. Use the drawdown chart below to compare losses from any high point for SGMT and PRCT.
Loading charts...
Drawdown Indicators
| SGMT | PRCT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.69% | -78.17% | -11.52% |
Max Drawdown (1Y)Largest decline over 1 year | -55.57% | -66.63% | +11.06% |
Max Drawdown (3Y)Largest decline over 3 years | — | -78.17% | — |
Current DrawdownCurrent decline from peak | -62.76% | -73.52% | +10.76% |
Average DrawdownAverage peak-to-trough decline | -65.96% | -31.67% | -34.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.39% | 48.15% | -14.76% |
Volatility
SGMT vs. PRCT - Volatility Comparison
The current volatility for Sagimet Biosciences Inc. (SGMT) is 17.43%, while PROCEPT BioRobotics Corporation (PRCT) has a volatility of 20.70%. This indicates that SGMT experiences smaller price fluctuations and is considered to be less risky than PRCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SGMT | PRCT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.43% | 20.70% | -3.27% |
Volatility (6M)Calculated over the trailing 6-month period | 60.82% | 48.16% | +12.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 104.39% | 59.94% | +44.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 151.73% | 64.85% | +86.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 151.73% | 64.85% | +86.88% |
Dividends
SGMT vs. PRCT - Dividend Comparison
Neither SGMT nor PRCT has paid dividends to shareholders.
Financials
SGMT vs. PRCT - Financials Comparison
This section allows you to compare key financial metrics between Sagimet Biosciences Inc. and PROCEPT BioRobotics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SGMT and PRCT have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRCT has higher volatility (20.70%) compared to SGMT (17.43%). In terms of maximum drawdown, SGMT dropped -89.69% vs PRCT's -78.17%.
SGMT currently has the higher Sharpe Ratio (0.86 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SGMT and PRCT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer